Preclinical anticancer activity of DNA-based cleavage molecules.
about
Non-viral methods for gene transfer towards osteosarcoma therapy.Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer.The advantages of being locked. Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes.Mapping of the functional phosphate groups in the catalytic core of deoxyribozyme 10-23.
P2860
Preclinical anticancer activity of DNA-based cleavage molecules.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Preclinical anticancer activity of DNA-based cleavage molecules.
@ast
Preclinical anticancer activity of DNA-based cleavage molecules.
@en
type
label
Preclinical anticancer activity of DNA-based cleavage molecules.
@ast
Preclinical anticancer activity of DNA-based cleavage molecules.
@en
prefLabel
Preclinical anticancer activity of DNA-based cleavage molecules.
@ast
Preclinical anticancer activity of DNA-based cleavage molecules.
@en
P2860
P1476
Preclinical anticancer activity of DNA-based cleavage molecules.
@en
P2093
Crispin R Dass
P2860
P356
10.1080/03639040500387872
P407
P577
2006-01-01T00:00:00Z